0001493152-21-023408.txt : 20210922 0001493152-21-023408.hdr.sgml : 20210922 20210922173734 ACCESSION NUMBER: 0001493152-21-023408 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210920 FILED AS OF DATE: 20210922 DATE AS OF CHANGE: 20210922 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: O'Malley Brendan M. CENTRAL INDEX KEY: 0001884342 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15771 FILM NUMBER: 211270399 MAIL ADDRESS: STREET 1: 1330 AVENUE OF THE AMERICAS STREET 2: 33RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ABEONA THERAPEUTICS INC. CENTRAL INDEX KEY: 0000318306 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 830221517 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1330 AVENUE OF THE AMERICAS, 33RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 646-813-4701 MAIL ADDRESS: STREET 1: 1330 AVENUE OF THE AMERICAS, 33RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 FORMER COMPANY: FORMER CONFORMED NAME: PLASMATECH BIOPHARMACEUTICALS INC DATE OF NAME CHANGE: 20140922 FORMER COMPANY: FORMER CONFORMED NAME: ACCESS PHARMACEUTICALS INC DATE OF NAME CHANGE: 19960209 FORMER COMPANY: FORMER CONFORMED NAME: CHEMEX PHARMACEUTICALS INC DATE OF NAME CHANGE: 19920703 4 1 ownership.xml X0306 4 2021-09-20 0 0000318306 ABEONA THERAPEUTICS INC. ABEO 0001884342 O'Malley Brendan M. 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019 0 1 0 0 SVP, General Counsel Common stock 2021-09-20 4 A 0 136000 0 A 273454 D Stock Option (right to buy) 1.21 2021-09-20 4 A 0 272000 0 A 2031-09-20 Common Stock 272000 272000 D The restricted stock will vest 25% on each of September 20, 2022, September 20, 2023, September 20, 2024 and September 20, 2025. The options will vest 25% on September 20, 2022, and in 36 equal monthly installments thereafter. /s/ Brendan O'Malley 2021-09-22